Alpha-arbutin
Stable tyrosinase inhibitor used for tone; EU caps 2% face / 0.5% body, with hydroquinone kept to trace.
Alpha-arbutin is the α-glucoside of hydroquinone. It inhibits tyrosinase more potently than the β-anomer in cell models while releasing far less free hydroquinone in well-made formulas[1][2].
What it does
It competes at tyrosinase and reduces melanin output in cultured melanocytes and reconstructed skin[2]. Clinically it is used for hyperpigmentation and uneven tone, often beside niacinamide, azelaic acid or kojic Acid. Evidence quality is moderate-to-limited: supportive mechanistic and small clinical work, fewer large monotherapy RCTs than for prescription hydroquinone.
The evidence
SCCS opinions (including SCCS/1642/22) conclude alpha-arbutin is safe at up to 2% in face creams and 0.5% in body lotions, including aggregate use with β-arbutin, provided hydroquinone stays at unavoidable trace levels[1][3]. In vitro, 0.5 mM alpha-arbutin cut melanin synthesis in HMV-II cells without blocking tyrosinase mRNA[2]. Combination cosmetics with alpha-arbutin plus kojic acid have shown melasma improvements in small randomised pilots, but isolate effect sizes are harder to parse[4].
How to use it
EU Regulation (EU) 2024/996 wrote those SCCS limits into Annex III[3]. Typical serums use 1–2% on face. Pair with daily sunscreen (zinc oxide/titanium dioxide or organic filters). Avoid expecting hydroquinone-level clearing from cosmetic strengths alone.
Evidence by claim
Safety & limits
Sources · 4
- [1]SCCS. Opinion on the safety of alpha-arbutin and beta-arbutin in cosmetic products (SCCS/1642/22). European Commission SCCS (2023)regulation
- [2]Sugimoto K, Nishimura T, Nomura K, et al.. Inhibitory effects of alpha-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model. Biological & Pharmaceutical Bulletin (2004)doi:10.1248/bpb.27.510
- [3]European Commission. Commission Regulation (EU) 2024/996 amending Regulation (EC) No 1223/2009 (Alpha-Arbutin Annex III). Official Journal of the European Union (2024)regulation
- [4]Kanokrungsee S, et al.. The Efficacy of Topical Cosmetic Containing Alpha-Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for Melasma. Journal of Cosmetic Dermatology (2024)doi:10.1111/jocd.16645